rediff.com
REAL-TIME QUOTE
Enter Company or MF
e.g. Tata motors, Reliance MF, 500570
SHARON BIO-MEDICINE LTD. - Board Meeting Intimation for Unaudited Financial Results For The Quarter And Half Year Ended September 30, 2020.
Download announcement < Back
05 Nov 2020
SHARON BIO-MEDICINE LTD.-$has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/11/2020 ,inter alia, to consider and approve Pursuant to Regulation 29 of the SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015, the Unaudited Financial Results of the Company for the quarter and half year ended September 30, 2020 along with the Limited Review Report of the Auditors thereon will be considered and approved on Wednesday, November 11, 2020 at the corporate office of the Company at 601, Proxima, Plot No. 19, Sector-30 (A), Vashi, Navi Mumbai-400705.&lt;BR&gt; &lt;BR&gt; As per the Company&apos;&apos;s code of conduct to regulate, monitor and report trading in securities of the Company, the trading window for dealing in the securities of the Company was closed from October 1, 2020 and will open Forty Eight (48) hours after the declaration of said financial results for the quarter and half year ended September 30, 2020.&lt;BR&gt; &lt;BR&gt; This is for your information and record.&lt;BR&gt;
View all announcements for SHARON BIO-MEDICINE LTD. Source: BSE India